Novo Nordisk started a new collaboration with Abbott and its Freestyle Libre line of digital health tools and continuous glucose monitoring devices.
The FDA has greenlighted a mobile app from Hygieia to be used as part of d-Nav, its insulin management service.
The FDA has approved a new type of insulin pump that can be used with different components from other diabetes therapy systems.
The Federal Trade Commission is requesting additional information from Boston Scientific and BTG ahead of their proposed $4.2 billion deal.
MUSC and Medtronic have signed on to a value-based healthcare collaboration, to reduce the cost of chronic conditions through standard care pathways.
Sight Diagnostics, maker of point-of-care blood diagnostic hardware, raised $27.8 million to continue its expansion and fund U.S. regulatory efforts.
Johnson & Johnson is diving deeper into robotic surgery with a $3.4 billion deal for Auris Health, designer of endoscopes aimed at lung cancer.
Hologic launched management software for its mammography machines that can predict the failure of X-ray hardware and help schedule early replacements.
Trice Medical plans to acquire S.E.G-Way Orthopaedics to offer both diagnostic and surgical solutions for minimally invasive orthopedic procedures.
The Canada-based units of Boehringer Ingelheim and IBM will work together to employ blockchain record-keeping technology in clinical trials.
